Lymphoblastic Leukemia in Children
7 clinical trials · Condition
◉ Watch Lymphoblastic Leukemia in Children
| Record | Firm | Date |
|---|---|---|
| Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia (NCT05429905) | KK Women's and Children's Hospital | 2022-07-18 |
| CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol (NCT05648019) | KK Women's and Children's Hospital | 2022-03-15 |
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571) | National University Hospital, Singapore | 2021-09-08 |
| ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. (NCT05038696) | National University Hospital, Singapore | 2021-04-28 |
| Association Between Mitochondrial DNA Content and Risk of Acute Leukemia (NCT03595969) | Air Force Military Medical University, China | 2018-11-01 |
Track Lymphoblastic Leukemia in Children automatically
Every clearance here is in the API, with alerts when new ones post.